MethodRP-HPLC (USP <621>)ColumnC18, 4.6 x 150 mm, 3.5 umMobile phaseA: 0.1% TFA in water / B: 0.1% TFA in acetonitrileGradient5-65% B over 20 minDetectionUV 214 nmFlow rate1.0 mL/minInjection10 uLRetention time8.42 min
Notes & Methodology
Peptide purity determined by RP-HPLC area normalization at 214 nm. The reported value is the percentage of the target peptide relative to all peptide-related peaks. Non-peptide process-related impurities, if detected, are excluded from the calculation.
Identity confirmed by comparison of chromatographic retention time against a characterized reference standard.
Elemental impurities analyzed by ICP-MS following USP <233> methodology. Acceptance criteria are internal laboratory screening limits for research-use materials and do not represent evaluation against any pharmacopeial monograph or product specification.
Sterility screening performed by PCR (polymerase chain reaction). This is a nucleic-acid detection method and is not equivalent to a compendial sterility test.
Bacterial endotoxin determined by USP <85> kinetic chromogenic method.
This certificate reports analytical results for the sample(s) submitted to United Diagnostics for testing. Sample identification, product name, brand, lot number and labeled content are provided by the submitting party and have not been independently verified. Results reflect only the analytical testing of the specific sample(s) provided and do not constitute an evaluation or endorsement of the manufacturer's processes, quality systems, or overall production.
United Diagnostics makes no representations regarding the intended use, safety, efficacy, regulatory status, or intellectual property ownership of any material tested. Materials tested are for research use only and are not for human or veterinary use, and not for diagnostic or therapeutic use.